The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of He Wei-wu since 2012.
This trader's CIK number is 1542073.
At the time of last reporting, He Wei-wu was the Chairman and CEO of Casi Pharmaceuticals, Inc.. (stock ticker symbol CASI).
Also see all insider trading activities at Casi Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CASI | 3,880,000 | $7,157,799 | 0 | $0 | 0 | $0 |
| 2020 | CASI | 6,436,469 | $12,046,287 | 0 | $0 | 0 | $0 |
| 2019 | CASI | 180,000 | $571,200 | 0 | $0 | 0 | $0 |
| 2018 | CASI | 3,086,419 | $9,999,997 | 0 | $0 | 0 | $0 |
| 2017 | CASI | 822,829 | $1,344,325 | 0 | $0 | 0 | $0 |
| 2016 | CASI | 1,871,605 | $2,227,209 | 0 | $0 | 0 | $0 |
| 2012 | CASI | 441,072 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-17 | CASI | Buy | 200,000 | .99 | 198,000 |
| 2021-11-18 | CASI | Buy | 200,000 | .98 | 196,000 |
| 2021-08-19 | CASI | Buy | 180,000 | 1.26 | 226,800 |
| 2021-08-18 | CASI | Buy | 300,000 | 1.29 | 387,000 |
| 2021-03-26 | CASI | Buy | 3,000,000 | 2.05 | 6,149,999 |
| 2020-11-23 | CASI | Buy | 100,000 | 2.18 | 218,000 |
| 2020-11-20 | CASI | Buy | 127,471 | 2.12 | 270,238 |
| 2020-07-22 | CASI | Buy | 4,152,426 | 1.90 | 7,889,609 |
| 2020-05-19 | CASI | Buy | 29,801 | 2.03 | 60,496 |
| 2020-05-20 | CASI | Buy | 56,464 | 2.37 | 133,819 |
| 2020-05-15 | CASI | Buy | 100,000 | 1.82 | 182,000 |
| 2020-05-18 | CASI | Buy | 338,932 | 2.02 | 684,642 |
| 2020-03-27 | CASI | Buy | 6,880 | 2.08 | 14,310 |
| 2020-03-25 | CASI | Buy | 196,398 | 1.94 | 381,012 |
| 2020-03-26 | CASI | Buy | 328,095 | 2.09 | 685,718 |
| 2020-03-17 | CASI | Buy | 264,192 | 1.50 | 396,288 |
| 2020-03-18 | CASI | Buy | 501,322 | 1.52 | 762,009 |
| 2020-03-19 | CASI | Buy | 234,488 | 1.57 | 368,146 |
| 2019-08-16 | CASI | Buy | 20,000 | 3.20 | 64,000 |
| 2019-08-14 | CASI | Buy | 160,000 | 3.17 | 507,200 |
| 2018-03-19 | CASI | Buy | 3,086,419 | 3.24 | 9,999,997 |
| 2017-10-10 | CASI | Buy | 100,000 | 1.95 | 195,000 |
| 2017-10-06 | CASI | Buy | 100,000 | 1.86 | 186,000 |
| 2017-10-05 | CASI | Buy | 100,000 | 1.80 | 180,000 |
| 2017-09-18 | CASI | Buy | 173,500 | 1.75 | 303,625 |
| 2017-09-19 | CASI | Buy | 34,002 | 1.78 | 60,523 |
| 2017-09-14 | CASI | Buy | 187,625 | 1.22 | 228,902 |
| 2017-09-15 | CASI | Buy | 127,702 | 1.49 | 190,275 |
| 2016-10-03 | CASI | Buy | 1,871,605 | 1.19 | 2,227,209 |
| 2012-05-01 | ENMD | Buy | 441,072 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by He Wei-wu (Chairman and CEO of Casi Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.